 AFP | Feuding antibodies block HIV vaccine Bangkok Post WASHINGTON - US researchers said Monday that a high-profile HIV vaccine trial that was shown to work in just under a third of patients may have been hindered by feuding antibodies. The vaccine trial, known as RV144, involved more than 16,000 HIV ... Competing antibodies may have limited the protection achieved in HIV vaccine ... |
